Asked by: Baroness Hodgson of Abinger (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether they have published guidance endorsing the use of selective internal radiation therapy; and what plans they have, if any, to encourage hospitals to achieve ENETS centre status, as awarded by the European Neuroendocrine Tumor Society.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
No guidance has been published endorsing this particular treatment. Radiotherapy treatment for cancer is highly individualised and decisions about cancer treatment are typically made by clinicians and multidisciplinary teams of healthcare professionals. They consider all aspects of a patient's health and circumstances when recommending treatment options. While certain treatments may not be advised for some patients, these decisions are based on medical assessments, and what is best for the individual's overall health and well-being.
There are no plans to specifically encourage hospitals to achieve this status. Currently there are 10 European Neuroendocrine Tumour Society Centres of Excellence in England.
Asked by: Baroness Hodgson of Abinger (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to increase funding for minimally invasive cancer therapies, in particular selective internal radiation therapy for neuroendocrine tumours that have spread to the liver.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Radiotherapy treatment for cancer is highly individualised and decisions about cancer treatment are typically made by clinicians and multidisciplinary teams of healthcare professionals. They consider all aspects of a patient's health and circumstances when recommending treatment options. While certain treatments may not be advised for some patients, these decisions are based on medical assessments and what is best for the individual's overall health and well-being.
The National Cancer Plan, coming later this year, will set out how we will seek to improve the experience and outcomes for people at every stage of the cancer pathway. It will look at how we can improve communication and coordination for patients, so that they feel informed, empowered, and in control of their care.
Asked by: Baroness Hodgson of Abinger (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the level of mycotoxins and rat excrement in imported grain.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Imported grain for human consumption is subject to surveillance monitoring by Port Health Authorities, and this includes physical checks that encompass mycotoxins and the presence of other extraneous matter. Imported consignments of grain that do not meet our food safety requirements are not allowed entry on to the British market.
The Food Standard Agency is not aware of any concerns relating to imported grain failing to meet food safety requirements.
Asked by: Baroness Hodgson of Abinger (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to deliver the Women's Health Strategy for England published on 30 August 2022, in particular with regard to recognising biological women.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to prioritising women’s health as we build a National Health Service fit for the future. We continue to implement the Women’s Health Strategy, for example providing support for pregnancy loss through a full rollout of baby loss certificates, menopause support in the workplace, and boosting women’s participation in research and clinical trials.
In the longer term, our priorities for delivering the strategy will be aligned with the 10-Year Health Plan and the Government's Missions. The 10-Year Health Plan will set out how we tackle the inequities that lead to poor health, including those for women.
The Government understands the need for health information to be as clear as possible and to use language that appropriately reflects sex, as defined as a protected characteristic in the Equality Act 2010. We expect the NHS to deliver health services in accordance with the Equality Act 2010, having appropriate regard to protected characteristics as defined in the Act where relevant.
Asked by: Baroness Hodgson of Abinger (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, further to their policy paper Confronting antimicrobial resistance 2024 to 2029, published on 8 May, how the importance placed on water, sanitation and hygiene (WASH) in that paper will be implemented; and whether there will be increased finance for WASH.
Answered by Lord Markham - Shadow Minister (Science, Innovation and Technology)
Proactive infection prevention and control, in terms of patient safety and antimicrobial resistance (AMR) within the public health system, is a core element of the national action plan.
Nationally, the UK Health Security Agency (UKHSA) works with partners to provide the evidence base and technical expertise to support best practice in infection prevention and control (IPC) in health and care and other settings, such as schools and prisons. A dedicated research facility at Porton Down also supports studies on the effectiveness of IPC procedures and the role of the built environment in AMR transmission.
Internationally, AMR activities are supported through a variety of global health initiatives. The World Health Organization (WHO) Collaborating Centre on AMR and Healthcare Associated Infections, which is housed by UKHSA, also provides support for training on AMR diagnostics and surveillance. School aged children can also learn about microbes, IPC, antibiotics and vaccination from free resources via the e-Bug programme.
The Government continues to finance WASH and global WASH leadership. levels of finance in 2025 and beyond will be confirmed by a Government-wide spending review.
Asked by: Baroness Hodgson of Abinger (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the prospects of equitable access to hospice care for all children and young people who need palliative and end of life care in 2024.
Answered by Lord Markham - Shadow Minister (Science, Innovation and Technology)
The Government recognises that access to high-quality, palliative and end of life care can make all the difference to individuals and their loved ones. Funding for children’s and young people’s palliative and end of life care is made available locally through integrated care boards (ICBs), which are responsible for commissioning services in response to the needs of their local population.
In addition, NHS England has confirmed that it will be renewing the Children and Young People’s hospice grant for 2024/25, once again allocating £25 million grant funding for children’s hospices. NHS England is reprioritising budgets for 2024/25, in light of the revised assessment of financial position and, whilst it is holding funding aside for the children and young people’s hospice sector, it cannot confirm further details, including the distribution mechanism, until 2024/25 financial planning is concluded.
Children and young people’s palliative and end of life care is provided by a range of services and providers from across the statutory and voluntary, community and social enterprise sectors. The majority of palliative and end of life care is provided by National Health Service staff and services, but we recognise that the voluntary sector organisations, including hospices, also play a very vital part in providing support to people at end of life and their loved ones.
The Government has not made a direct assessment of the prospects of equitable access to hospice care for all children and young people who need palliative and end of life care in 2024. However, NHS England’s palliative and end of life care team has recently engaged with 24 ICBs to understand how to better support commissioners and has also reviewed all 42 ICB Joint Forward Plans for their inclusion of palliative and end of life care, with 69% making a specific mention. Further analysis is ongoing, but the intention is to use this to help shape and focus support to ICBs.
Asked by: Baroness Hodgson of Abinger (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether they expect integrated care boards to be able to identify how many children and young people access children’s hospices; and what steps they will take if they cannot.
Answered by Lord Markham - Shadow Minister (Science, Innovation and Technology)
Children and young people’s palliative and end of life care is provided by a range of local services and providers from across the statutory and voluntary, community and social enterprise sectors, including hospices, with the experience and skills to meet those needs.
While there is no explicit requirement for integrated care boards (ICBs) to identify how many children and young people specifically access children's hospices, commissioning of children and young people’s palliative and end of life care services is the statutory duty of ICBs, which must commission these services in response to the needs of their population,
In July 2022, NHS England published statutory guidance for commissioners on palliative and end of life care, setting out the considerations for ICBs to meet their legal duties and makes clear reference to the importance of access to services. A copy of the guidance is attached.
NHS England has also published a service specification for children and young people which provide guidance on undertaking assessments to enable high-quality commissioning of services that meet both population need and preferences. A copy of the specification is attached.
Asked by: Baroness Hodgson of Abinger (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how much money was spent per case on palliative and end of life care for children and young people in (1) 2022, and (2) 2023; and how much they anticipate spending in 2024.
Answered by Lord Markham - Shadow Minister (Science, Innovation and Technology)
The Government does not hold information on how much money was spent per case on palliative and end of life care for children and young people in 2022 and 2023. Patient-level spend is not collated at a national level, with spend based on need determined during the integrated care board (ICB) commissioning process.
At a national level, NHS England supports palliative and end of life care for children and young people through the Children and Young People’s hospice grant. The grant provided approximately £17 million in 2021/22, £21 million in 2022/23 and £25 million in 2023/24 directly to children and young people’s hospices. NHS England has confirmed that it will be renewing the grant for 2024/25, once again allocating £25 million grant funding for children’s hospices using the same prevalence-based allocation approach as in 2022/23 and 2023/24. NHS England is reprioritising budgets for 2024/25, in light of the revised assessment of financial position and, whilst it is holding funding aside for the children and young people’s hospice sector, it cannot confirm further details, including the distribution mechanism, until 2024/25 financial planning is concluded.
Additionally, in line with the NHS Long Term Plan commitment, NHS England has provided approximately £8.5 million match-funding to participating ICBs and formerly clinical commissioning groups between 2022/23 and 2023/24 that committed to invest in children and young people’s palliative and end of life care, including hospices, giving a total investment of £17 million for that period.
Asked by: Baroness Hodgson of Abinger (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what directions and guidance the Department of Health and Social Care will provide to integrated care boards on commissioning palliative and end of life care for children and young people.
Answered by Lord Markham - Shadow Minister (Science, Innovation and Technology)
Children and young people’s palliative and end of life care is provided by a range of services and providers from across the statutory and voluntary, community and social enterprise sectors. Commissioning of these services is the statutory duty of integrated care boards (ICBs), which must commission palliative and end of life care services in response to the needs of their local population and ensure that they are provided by a range of local organisations with the experience and skills to meet those needs.
In July 2022, NHS England published statutory guidance for commissioners on palliative and end of life care, setting out the considerations for ICBs to meet their legal duties. A copy of this guidance is attached.
NHS England has also published a service specification for children and young people, which provides guidance on undertaking assessments to enable high-quality commissioning of services that meet both population need and preferences. A copy of this specification is attached.
NHS England’s palliative and end of life care team has recently engaged with 24 ICBs to understand how to better support commissioners, and has also reviewed all 42 ICB Joint Forward Plans for their inclusion of palliative and end of life care, with 69% of those plans making a specific mention. Further analysis is ongoing, but the intention is to use this information to help shape and focus support to ICBs.
Asked by: Baroness Hodgson of Abinger (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how many infants admitted to the Somerset NHS Foundation Trust in each of the past five years were subject to investigation under its guidelines regarding suspected abuse in children; of those, how many were identified as having been subjected to abuse; and whether this figure is similarly reflected in other trusts across the country.
Answered by Lord Markham - Shadow Minister (Science, Innovation and Technology)
Somerset NHS Foundation Trust guidelines define abuse and neglect as forms of maltreatment of a child. Somebody may abuse or neglect a child by inflicting harm, or by failing to act to prevent harm. All staff have a responsibility to safeguard children at risk of abuse or neglect in the National Health Service. This involves protecting children from maltreatment and preventing impairment of children’s health and development. Somerset NHS Foundation Trust does not hold data on the number of infants admitted in the past five years subject to investigation regarding suspected abuse or the number of infants identified as subjected to abuse. NHS England also does not collect the data requested.